Dog

Items 261-270 of 343

per page
Set Descending Direction
  1. Neuronal ceroid lipofuscinosis type 5 (CLN5: c.934_935delAG)

    Test code: DOG-NCL5GR
    Neural ceroid-lipofuscinosis is a genetic defect characterised by progressive behavioural changes, hyperactivity, dementia, aggression, loss of coordination, ataxia, delayed postural responses, blindness and slow responses to pupillary light.
    €49.85
  2. Neuronal ceroid lipofuscinosis type 5 (CLN5: c.619C>T)

    Test code: DOG-NCL5

    Neuronal ceroid lipofuscinosis is a genetic defect characterised by progressive behavioural changes, hyperactivity, dementia, aggression, loss of coordination, ataxia, delayed postural responses, blindness and slow responses to pupillary light.

    €49.85
  3. Neuronal ceroid lipofuscinosis type 6 (CLN6: c.829T>C)

    Test code: DOG-NCL6

    Neuronal ceroid lipofuscinosis is a genetic defect characterised by a visual deficit that progresses to complete blindness, as well as progressive anxiety, cognitive and motor degeneration and lack of coordination.

    €49.85
  4. Neuronal ceroid lipofuscinosis type 7 (MFSD8: c.843delT)

    Test code: DOG-NCL7

    Neuronal ceroid lipofuscinosis is a genetic defect characterised by cognitive impairment, blindness and anxiety.

    €49.85
  5. Neuronal ceroid lipofuscinosis type 10 (CTSD: c.597G>A)

    Test code: DOG-NCL10

    Neuronal ceroid lipofuscinosis is a genetic defect whose first clinical signs usually appear before the age of 2 years and include hypermetriosis, dysmetria, paraparesis, ataxia and progressive psychomotor degeneration. Unlike many other NCLs, American bulldogs with NCL10 do not show signs of brain dysfunction or blindness.

    €49.85
  6. Neonatal encephalopathy (ATF2: c.152T>G)

    Test code: DOG-NEWS
    Neonatal encephalopathy is a malformation of the cerebellum seen in poodles. Affected puppies are small at birth and do not develop normally. At the age of about 3 weeks, weakness, ataxia, tremors are observed. Affected puppies do not interact with the mother or other members of the litter and react slowly to external stimuli. They usually die or are euthanised before 7 weeks of age.
    €49.85
  7. Osteogenesis imperfecta (COL1A1: c.1276G>C)

    Test code: DOG-OSTEO-GR
    Osteogenesis imperfecta, also known as brittle bone disease, is characterised by extreme fragility of bones and teeth caused by an abnormal collagen structure.
    €49.85
  8. Phosphofructokinase deficiency (PFKM: c.2228G>A)

    Test code: DOG-PFKM
    Phosphofructokinase deficiency is an inherited glycogen storage disease. Without the enzyme phosphofructokinase, muscle cells and red blood cells are not able to produce enough energy to meet their needs. Clinical signs are weakness, lethargy, exercise intolerance and anaemia.
    €49.85
  9. Pyruvate kinase deficiency (PKLR: c.848T>C)

    Test code: DOG-PKDEFC
    Pyruvate kinase is an essential enzyme for energy production in red blood cells. Clinical signs are anaemia, weakness, hepatosplenomegaly. Bone marrow and liver failure usually occur before the age of 5 years. Heterozygous animals (healthy carriers) show no clinical signs, but have reduced levels of pyruvate kinase activity. Bone marrow transplants have been used to alleviate clinical signs in affected dogs.
    €49.85
  10. Pyruvate kinase deficiency (PKLR: c.799C>T)

    Test code: DOG-PKDEFL
    Pyruvate kinase is an essential enzyme for energy production in red blood cells. Clinical signs are anaemia, weakness, hepatosplenomegaly. Bone marrow and liver failure usually occur before the age of 5 years. Heterozygous animals (healthy carriers) show no clinical signs, but have reduced levels of pyruvate kinase activity. Bone marrow transplants have been used to alleviate clinical signs in affected dogs.
    €49.85

Items 261-270 of 343

per page
Set Descending Direction